1. Market Research
  2. > Pathology
45 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

ASIA PACIFIC AUTOTRANSFUSION DEVICES AND CONSUMABLES MARKET FORECAST 2019-2027

  • $ 1250
  • August 2019
  • 92 pages

LYMPHOMA IN THE UNITED STATES 2019 (%) FIGURE ## ASIA PACIFIC AUTOTRANSFUSION DEVICES AND CONSUMABLES MARKET SHARE BY PRODUCT TYPE 2018 & 2027 (%) FIGURE ## ASIA PACIFIC AUTOTRANSFUSION DEVICES AND CONSUMABLES MARKET, BY DEVICES, 2019-2027 ($ MILLION) FIGURE ## ASIA PACIFIC AUTOTRANSFUSION

  • Healthcare
  • Lymphoma
  • APAC

Tissue Diagnostics Market Size, Outlook and Growth Opportunities, 2019- 2025

  • $ 4580
  • June 2019
  • 130 pages

Global Tissue Diagnostics Market Outlook by Disease ##. ## Breast Cancer ##. ## Gastric Cancer ##. ## Lymphoma ##. ## Prostate Cancer ##. ## Non-Small Cell Lung Cancer (NSCLC) ##. ## Others ##.

  • Diagnostics
  • Lymphoma
  • APAC
  • World
  • Market Size

Hematology Diagnostics Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast, 2018 - 2026

  • $ 5795
  • May 2018
  • 228 pages

Lymphoma, or Myeloma in 2017 Figure ##: Global Hematology Diagnostics Market Value Share, by Product Type, 2017 and 2026 Figure ##: Global Hematology Diagnostics Market Value Share, by Hematology Instruments, 2017 and 2026 Figure ##: Global Hematology Diagnostics Market Revenue (US$ Mn) and

  • Diagnostics
  • Lymphoma
  • APAC
  • World
  • Market Size

Asia Pacific Veterinary Oncology Market By Animal Type By Therapy By Cancer Type By Country, Industry Analysis and Forecast, 2020 - 2026

  • $ 1500
  • April 2020
  • 90 pages

Based on Cancer Type, the market is segmented into Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Others.

  • Lymphoma
  • Oncology
  • Therapy
  • APAC
  • Market Size

Antibody Drug Conjugates Market by Drugs, Mechanism of Action, Application - Global Opportunity Analysis and Industry Forecast 2017-2023.

  • $ 3440
  • September 2017
  • 152 pages

LYMPHOMA ##. ##. ##.

  • Lymphoma
  • Medical Biotechnology
  • APAC
  • World
  • Forecast

World Hematology and Flow Cytometry Analyzers and Reagents Market, 2019-2023: Emerging Opportunities in the Americas, EMEA, APAC--A 74-Country Analysis

  • $ 37500
  • June 2019
  • 1175 pages

Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/ RNA Analysis, Cell Culturing Instrumentation Review - Reviews of current instrumentation Technologies, and featu

  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • APAC
  • World

Asia-Pacific Colorectal Cancer Market to 2027 - Regional Analysis and Forecasts by Modality ; End User, and Country

  • $ 3000
  • March 2020
  • 166 pages

The largest impact is that it grows slowly, like solid tumors and leukemia, also used to treat lung, ovarian cancer, and breast cancer, as well as for lymphomas, sarcomas, myelomas.

  • Colorectal Cancer
  • Lymphoma
  • APAC
  • Forecast
  • Market Size

In Vitro Diagnostics – A Global Market Overview

  • $ 4500
  • August 2017
  • 498 pages

KEY BUSINESS & PRODUCT TRENDS cobas MRSA/ SA test Launched by Roche ClearLLab Reagents Cleared by FDA for Specific Leukemia and Lymphoma Detection FDA Approves Hologic’s Aptima HSV ## & ## Molecular Assay CE Mark Allotted to Thermo Fisher’s Innovative Buprenorphine-Detecting Immun

  • Diagnostics
  • In Vitro Diagnostics
  • Lymphoma
  • APAC
  • Market Size

Asia Pacific Apheresis Market - Growth, Trends, and Forecast (2019-2024)

  • $ 3750
  • August 2019
  • 70 pages

According to the Asia-Pacific Report by Janssen Oncology, in 2017, there were ##, ## combined new cases of leukemia, lymphoma, and myeloma in Australia.

  • Blood Supply
  • Lymphoma
  • APAC
  • Forecast
  • B. Braun Melsungen AG

Asia Pacific Biopsy Devices Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product, Technology, Application, and Country

  • $ 3000
  • July 2020
  • 142 pages

These procedures are mostly employed as a diagnostic test for cancers such as breast cancer, lymphoma, lung cancer and others.

  • Biopsy
  • Diagnostics
  • Injectable Delivery
  • Lymphoma
  • APAC

Hematological Malignancies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • November 2016
  • 152 pages

Lymphoma ##. ##.

  • Cancer
  • Lymphoma
  • Pathology
  • APAC
  • Market Size

Immune Checkpoint Inhibitors Market by Type and Application - Global Opportunity Analysis and Industry Forecast, 2018-2025

  • $ 3840
  • September 2018
  • 149 pages

Immune Checkpoint Inhibitors Market by Type and Application - Global Opportunity Analysis and Industry Forecast, 2018-2025 CHAPTER ##: INTRODUCTION ##. ##.

  • Lymphoma
  • Therapy
  • APAC
  • World
  • Forecast

2024 Asia-Pacific Hematology and Flow Cytometry Analyzers and Reagents Market: A 17-Country Analysis

  • $ 9500
  • July 2020
  • 365 pages

Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/ RNA Analysis, Cell Culturing Instrumentation Review - Reviews of current instrumentation technologies, and featu

  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • APAC
  • Australasia

Asia-Pacific Hematology and Flow Cytometry Analyzers and Reagents Market for Over 40 Tests: A 17-Country Analysis--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review, Emerging Opportunities

  • $ 9500
  • September 2019
  • 365 pages

Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/ RNA Analysis, Cell Culturing Instrumentation Review - Reviews of current instrumentation Technologies, and featu

  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • APAC
  • Australasia

2019 Lymphoplasmacytic Lymphoma Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

  • $ 2199
  • February 2019
  • 176 pages

Lymphoplasmacytic Lymphoma Clinical Trial Trends ##. ## Start Year wise Ongoing Lymphoplasmacytic Lymphoma Clinical Trials ##. ## Phase wise Ongoing Lymphoplasmacytic Lymphoma Clinical Trials ##. ## Trial Status wise Ongoing Lymphoplasmacytic Lymphoma Clinical Trials ##. ## T

  • Cancer
  • Clinical Trial
  • Drug Development
  • Lymphoma
  • APAC

2019 Lymphoblastic Lymphoma Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

  • $ 2199
  • February 2019
  • 150 pages

Lymphoblastic Lymphoma Clinical Trial Trends ##. ## Start Year wise Ongoing Lymphoblastic Lymphoma Clinical Trials ##. ## Phase wise Ongoing Lymphoblastic Lymphoma Clinical Trials ##. ## Trial Status wise Ongoing Lymphoblastic Lymphoma Clinical Trials ##. ## Trial Type wise O

  • Cancer
  • Clinical Trial
  • Drug Development
  • Lymphoma
  • APAC

2019 Follicular Lymphoma Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

  • $ 2199
  • February 2019
  • 413 pages

Follicular Lymphoma Clinical Trial Trends ##. ## Start Year wise Ongoing Follicular Lymphoma Clinical Trials ##. ## Phase wise Ongoing Follicular Lymphoma Clinical Trials ##. ## Trial Status wise Ongoing Follicular Lymphoma Clinical Trials ##. ## Trial Type wise Ongoing Folli

  • Cancer
  • Clinical Trial
  • Drug Development
  • Lymphoma
  • APAC

2019 Burkitt Lymphoma Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

  • $ 2199
  • February 2019
  • 142 pages

Burkitt Lymphoma Clinical Trial Trends ##. ## Start Year wise Ongoing Burkitt Lymphoma Clinical Trials ##. ## Phase wise Ongoing Burkitt Lymphoma Clinical Trials ##. ## Trial Status wise Ongoing Burkitt Lymphoma Clinical Trials ##. ## Trial Type wise Ongoing Burkitt

  • Cancer
  • Clinical Trial
  • Drug Development
  • Lymphoma
  • APAC

2019 AIDS Related Lymphoma Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

  • $ 2199
  • February 2019
  • 45 pages

AIDS Related Lymphoma Clinical Trial Trends ##. ## Start Year wise Ongoing AIDS Related Lymphoma Clinical Trials ##. ## Phase wise Ongoing AIDS Related Lymphoma Clinical Trials ##. ## Trial Status wise Ongoing AIDS Related Lymphoma Clinical Trials ##. ## Trial Type wise Ongoi

  • Cancer
  • Clinical Trial
  • Drug Development
  • Lymphoma
  • APAC

Asia-Pacific Hematology and Flow Cytometry Analyzers and Reagents Market, 2019-2023: A 17-Country Analysis--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review, Emerging Opportunities

  • $ 14700
  • June 2019
  • 365 pages

Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/ RNA Analysis, Cell Culturing Instrumentation Review - Reviews of current instrumentation Technologies, and featu

  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • APAC
  • Australasia
View report >

Pharmaceutical Markets

  • October 2017
  • 19 pages

For chronic lymphocytic leukaemia (CLL), rituximab-refractory follicular lymphoma and previously untreated advanced follicular lymphoma.

  • Lymphoma
  • Pharmaceutical
  • APAC
  • Demand
  • Roche Group

Diagnostics Markets October 2015

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on